Physician profile
Surbhi Chamaria
NPI 1649583923
$3,326.88
in general payments reported to CMS, 2019-2025
19 companies · $78.43 in 2025
The $78.43 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,312 · 2020: $128 · 2021: $532 · 2022: $411 · 2023: $492 · 2024: $375 · 2025: $78.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $945.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $985.00 | 2019-2024 | Angiojet Ultra 5000a |
| Abiomed | $501.11 | 2021-2024 | Impella |
| Janssen Pharmaceuticals, INC | $352.66 | 2019-2024 | Xarelto |
| Abbott Laboratories | $267.21 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $242.30 | 2021-2025 | |
| Medtronic, INC. | $228.64 | 2022-2025 | Cobalt Dr Mri Surescan, Linq II, Micra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $216.60 | 2019-2025 | Lifevest |
| Amgen INC. | $132.07 | 2019-2021 | |
| Shockwave Medical, INC | $120.54 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $94.27 | 2019-2021 | |
| Amarin Pharma, INC. | $42.79 | 2019-2021 | |
| Cardiva Medical, INC. | $35.42 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Medtronic Vascular, INC. | $22.81 | 2019 | |
| Inari Medical, INC. | $20.22 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Novo Nordisk INC | $20.22 | 2024 | Rybelsus, Ozempic |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $16.12 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.50 | 2019 | |
| Philips North America LLC | $13.40 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Surbhi Chamaria listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.